Eltrekibart

Eltrekibart (LY3041658) is a "septa-specific monoclonal antibody that neutralizes all seven ELR+ CXC chemokines (CXCL1-3 and CXCL5-8), thereby limiting signaling through CXCR1 and CXCR2". It was tested in clinical trials for hidradenitis suppurativa.